Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy
Jin Gao, Jing-Ye Hu, Yun-Fei Xia , Wei Yi, Ya-Lan Tao, Guo Li
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P. R. China. xiayunfei@yahoo.com
[Abstract] Background and Objective: Anemia can not only reduce the quality of life of patients with cancer, but also affect their survival. This study was to investigate the prognostic value of hemoglobin (Hb) level in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy. Methods: Clinical data of 520 NPC patients received definitive radiotherapy between 2000 and 2002 at Sun Yatsen University Cancer Center were analyzed. Patients were stratified into normal Hb level and anemia groups according to their Hb levels before, during, and after radiation. Anemia was defined according to World Health Organization criteria as Hb level < 130 g/L in men and < 120 g/L in women. Hb continuous decrease group and nondecrease group were defined according to Hb changes in the patients during radiotherapy. Locoregional recurrencefree survival (LRFS) and overall survival (OS) rates were estimated using the KaplanMeier method. Multivariate analysis was performed using the Cox model to analyze the prognostic factors. Results: Before radiation, the 5year LRFS rates were 60.9% in anemia group and 63.9% in normal Hb level group (P = 0.337); the 5year OS rates were 65.2% and 71.0%, respectively (P = 0.299). During radiation, the 5year LRFS rates were 56.7% in anemia group and 67.9% in normal Hb level group (P = 0.013); the 5year OS rates were 61.0% and 75.9%, respectively (P = 0.001). After radiation, the 5year LRFS rates were 59.6% in anemia group and 64.9% in normal Hb level group (P = 0.169); the 5year OS rates were 65.0% and 71.9%, respectively (P = 0.090). The 5year LRFS and OS rates were significantly lower in Hb continuous decrease group than in Hb nondecrease group (59.1% vs. 69.3%, P = 0.032; 66.2% vs. 76.4%, P=0.011). Multivariate analysis showed that the continuous decrease of Hb was an independent prognostic factor for OS. Conclusion: The change in Hb level during radiotherapy is an important prognostic factor affecting the OS of NPC patients.
Chinese Journal of Cancer 2010, Volume: 29, Issue 5, Page: 561-566
SHARE THIS ARTICLE
Comments: